BETHASONE-N

This brand name is authorized in Nigeria.

Active ingredients

The drug BETHASONE-N contains a combination of these active pharmaceutical ingredients (APIs):

1	Betamethasone UNII 7BK02SCL3W - BETAMETHASONE SODIUM PHOSPHATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone
2	Neomycin UNII 057Y626693 - NEOMYCIN SULFATE
	Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
	Read more about Neomycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0004	Ear/eye drops	Reagan Bethasone-N Ear and Eye Drops SOL_DROPS 0.1%; 0.5% Drops x 5ml	REAGAN BETHASONE-N EAR AND EYE DROPS A11-0004 REAGAN Betamethasone Sodium Phosphate 0.1%w/v, Neomycin Sulphate 0.5% w/v Antibiotics Drops POM Used to reduce Inflamation, swelling and bacterial infections associated with the eye Reagan Remedies Limited 24, Musa Yar'Adua Drive, New Owerri, Imo State Same as applicant Same as applicant 26/01/2023 25/01/2028	26/01/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S03CA06	Betamethasone and antiinfectives	S Sensory organs → S03 Ophthalmological and otological preparations → S03C Corticosteroids and antiinfectives in combination → S03CA Corticosteroids and antiinfectives in combination
Discover more medicines within S03CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0004